What is the societal significance of precision medicine? How much do we know about the genetics of the Norwegian population? In this episode, Eivind and Silvija discuss how mutations in cancer interact with the immune system and predictions on how we can manipulate such mutations.
This article is from an episode of #Lørn, made in collaboration with LørnTech.
Who are you personally and professionally?
I am from a family that has an academic background, as both of my parents have had long careers in research at Rikshospitalet which is a part of OUH today. My parents have also worked with cancer research since they studied genetics as their major at Blindern (UiO) during the 70s. Since the late 90s, I have been working with data to organize knowledge about different aspects of genes that could mutate in cancer, and have continued to work more on this issue over the years.
Recommended literature / videos about your professional field?
Focus is usually directed towards bioinformatic solutions. Such solutions are the product of innovation, or opportunities that emerge along the way in research. However, innovations is not a focus.